J & D Pharmaceuticals
J & D Pharmaceuticals is dedicated to discovering, developing, and delivering safe and effective treatments for serious diseases, particularly focusing on traumatic brain injury, burns, and operative pain. Their innovative approach combines salicylic acid with liposomal technology to enhance drug delivery and efficacy, aiming to improve patient outcomes while minimizing side effects.
What We Do
Innovative Anti-Inflammatory Technology
Utilizing a proprietary liposomal formulation technology to enhance the safety and efficacy of salicylic acid-based treatments.
Targeted Treatments for Military-Related Conditions
Developing formulations specifically aimed at addressing traumatic brain injury, burns, and post-operative pain.
A novel formulation aimed at treating traumatic brain injury and related conditions, leveraging the safety of phosphatidylcholine to reduce gastrointestinal risks associated with traditional NSAIDs.
A plant-based salicylic acid formulation designed for various applications, including treatment for Autosomal Dominant Polycystic Kidney Disease and Progeria.
Vaccines
News & Updates
J & D Pharmaceuticals received FDA orphan drug designation for JD-004 and JD-005 for the treatment of Progeria and related conditions.